Tetragenetics Anti-Kv1.3 Antibody Patent EP3452084A1
Summary
The European Patent Office published patent application EP3452084A1 for Tetragenetics, Inc., titled 'ANTI-KV1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF,' with a publication date of April 15, 2026. The patent covers anti-Kv1.3 antibodies and their production and use, classified under A61P 37/06 for autoimmune and inflammatory disease applications. Designated states include all 31 EPC contracting states across the European Union and beyond.
“ANTI-KV1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF”
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.
What changed
The European Patent Office published patent EP3452084A1, granted to Tetragenetics, Inc., covering anti-Kv1.3 antibodies and their methods of production and therapeutic use for treating autoimmune and inflammatory diseases. The patent is classified under IPC codes A61K 39/00, C07K 16/00, C07K 16/28, and A61P 37/06 (immunological disorders). Named inventors include Marien, Van der Woning, De Haard, Harriman, Collarini, Bednenko, Bisharyan, Papoyan, Cardarelli, Clark, Kahn, and Agrawal.
For pharmaceutical and biotechnology companies developing immunomodulatory therapies, this patent grants Tetragenetics enforceable exclusive rights in all 31 designated EPC contracting states, potentially blocking competing anti-Kv1.3 programs and creating opportunities for licensing or partnership discussions.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-KV1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF
Publication EP3452084A1 Kind: A1 Apr 15, 2026
Applicants
Tetragenetics, Inc.
Inventors
MARIEN, Lore, VAN DER WONING, Bas, DE HAARD, Hans, HARRIMAN, William, D., COLLARINI, Ellen, J., COLUSSI, Paul, BEDNENKO, Janna, BISHARYAN, Yelena, PAPOYAN, Ashot, CARDARELLI, Joanna, CLARK, Theodore, G., KAHN, R. Douglas, AGRAWAL, Alka
IPC Classifications
A61K 39/00 20060101AFI20191122BHEP C07K 16/00 20060101ALI20191122BHEP C07K 16/44 20060101ALI20191122BHEP A61P 37/06 20060101ALI20191122BHEP C07K 16/28 20060101ALI20191122BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.